investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining the role of aberrant O-linked glycosylation in breast cancer
Joy Burchell
0 Collaborator(s)
Funding source
Medical Research Council (MRC)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Joy Burchell
King's College London
London, United Kingdom
Related projects
Xiaodong Zhang
Structural and mechanistic studies of the breast cancer tumour suppressor BRCA2 in DNA double strand break repair
Breast
Pathology
Esther Arwert
A leading role for macrophages in breast cancer metastasis.
Breast
Pathology
Richard G Pestell
Impact of Cyclin D1 Isoforms in Breast Cancer
Breast
Susan L Teitelbaum
Breast Cancer Genomics in Windows of Susceptibility to Endocrine Disruptors
Breast
Heide L Ford
Role of Six1 and the miR106b 25 Cluster in EMT and Tumor Progression
Breast
Global Noncommunicable Diseases Intiatives
Funding for exchange of scientists - 8
Breast
Global Noncommunicable Diseases Intiatives
Breast Cancer Project Kyrgyzstan - 2
Breast
Seok-Hyun Andy Yun
Bioluminecence-activated photodynamic therapy of breast cancer
Breast
Pilar Blancafort
Targeted epigenetic silencing of oncogenic Transcription Factors (PQ18)
Breast
Pathology
